Addition Therapeutics
USEntry
2025
Hold
1yr
Status
Active
Who owns Addition Therapeutics?
Addition Therapeutics is an American Biotech company, currently owned by Abingworth since 2025.
Hand-verified · updated 2026-07-08
Open JSON · CC-BY
More from Abingworth Bioventures IX
Other portfolio companies in the same fund.
More Abingworth portfolio companies
From the same investor, across funds.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Addition Therapeutics?
Addition Therapeutics is currently owned by Abingworth, through Abingworth Bioventures IX, since 2025.
When did Abingworth acquire Addition Therapeutics?
Abingworth acquired Addition Therapeutics in 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue